Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financial Disclosure Violations Are Unlikely To Warrant Clinical Holds – FDA

Executive Summary

Violations of FDA's financial disclosure requirements would be unlikely to lead to a clinical hold decision, FDA says in a draft guidance on investigator misconduct and clinical holds

You may also be interested in...



FDA Finalizes Guidance On Clinical Holds Due To Investigator Misconduct

FDA's final guidance on clinical holds due to clinical investigator misconduct drops some discussion of financial disclosure issues

FDA Finalizes Guidance On Clinical Holds Due To Investigator Misconduct

FDA's final guidance on clinical holds due to clinical investigator misconduct drops some discussion of financial disclosure issues

Next-Gen Smallpox, Anthrax Vaccines To Be First Use Of Animal Efficacy

A next-generation smallpox vaccine is expected to be the first product licensed under FDA's animal efficacy rule, HHS Office of the Assistant Secretary for Public Health Emergency Preparedness Senior Advisor Philip Russell, MD, said Aug. 28

Related Content

UsernamePublicRestriction

Register

PS040401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel